# Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease

> **NCT01016470** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 100 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DIETARY_SUPPLEMENT:** VIUSID/ALZER
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01016470
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016470, "Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01016470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*